Compare PAHC & EE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAHC | EE |
|---|---|---|
| Founded | 1946 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2014 | 2022 |
| Metric | PAHC | EE |
|---|---|---|
| Price | $35.16 | $36.51 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $41.25 | $39.20 |
| AVG Volume (30 Days) | 211.6K | ★ 346.7K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | 0.91% | ★ 0.96% |
| EPS Growth | ★ 104.20 | 0.79 |
| EPS | ★ 2.43 | 0.75 |
| Revenue | $833,350,000.00 | ★ $1,228,263,000.00 |
| Revenue This Year | $17.03 | $23.59 |
| Revenue Next Year | $3.82 | $24.37 |
| P/E Ratio | ★ $14.66 | $51.21 |
| Revenue Growth | 4.12 | ★ 44.26 |
| 52 Week Low | $28.25 | $23.55 |
| 52 Week High | $60.08 | $43.18 |
| Indicator | PAHC | EE |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 44.25 |
| Support Level | $30.55 | $37.64 |
| Resistance Level | $37.92 | $40.31 |
| Average True Range (ATR) | 1.60 | 1.53 |
| MACD | -0.25 | -0.19 |
| Stochastic Oscillator | 16.49 | 15.73 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Excelerate Energy Inc. offers comprehensive LNG solutions by providing integrated services throughout the LNG value chain. The company delivers a full range of regasification services, including Floating Storage and Regasification Units (FSRUs), infrastructure development, and the supply of LNG and natural gas. With operational presence in several countries - Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States. The company generates revenue through Terminal Services, as well as from LNG, gas, and power. These revenues are derived from its vertically integrated activities in LNG sourcing, transportation, regasification, and power generation.